BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Runyon BA. A Primer on Detecting Cirrhosis and Caring for These Patients without Causing Harm. Int J Hepatol. 2011;2011:801983. [PMID: 22121492 DOI: 10.4061/2011/801983] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Rinaldi L, Nascimbeni F, Giordano M, Masetti C, Guerrera B, Amelia A, Fascione MC, Ballestri S, Romagnoli D, Zampino R, Nevola R, Baldelli E, Iuliano N, Rosato V, Lonardo A, Adinolfi LE. Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. World J Gastroenterol 2017; 23(8): 1458-1468 [PMID: 28293093 DOI: 10.3748/wjg.v23.i8.1458] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
2 Barsuk JH, Cohen ER, Feinglass J, Kozmic SE, Mcgaghie WC, Ganger D, Wayne DB. Cost Savings of Performing Paracentesis Procedures at the Bedside After Simulation-based Education. Simulation in Healthcare: The Journal of the Society for Simulation in Healthcare 2014;9:312-8. [DOI: 10.1097/sih.0000000000000040] [Cited by in Crossref: 38] [Cited by in F6Publishing: 9] [Article Influence: 5.4] [Reference Citation Analysis]
3 Li CH, Chen HJ, Chen WC, Tu CY, Hsia TC, Hsu WH, Chang CT, Huang CC, Bau DT, Chou CY. The Risk of Tuberculosis Infection in Non-dialysis Chronic Kidney Disease Patients. Front Med (Lausanne) 2021;8:715010. [PMID: 34485344 DOI: 10.3389/fmed.2021.715010] [Reference Citation Analysis]
4 Martinez-Urbistondo D, Suarez Del Villar R, Argemí J, Daimiel L, Ramos-López O, San-Cristobal R, Villares P, Martinez JA. Antioxidant Lifestyle, Co-Morbidities and Quality of Life Empowerment Concerning Liver Fibrosis. Antioxidants (Basel) 2020;9:E1125. [PMID: 33202851 DOI: 10.3390/antiox9111125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Chang EK, Yu CY, Clarke R, Hackbarth A, Sanders T, Esrailian E, Hommes DW, Runyon BA. Defining a Patient Population With Cirrhosis: An Automated Algorithm With Natural Language Processing. J Clin Gastroenterol 2016;50:889-94. [PMID: 27348317 DOI: 10.1097/MCG.0000000000000583] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
6 Ballestri S, Capitelli M, Fontana MC, Arioli D, Romagnoli E, Graziosi C, Lonardo A, Marietta M, Dentali F, Cioni G. Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review. Adv Ther 2020;37:1910-32. [PMID: 32285340 DOI: 10.1007/s12325-020-01307-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 22.0] [Reference Citation Analysis]
7 Hayashi H, Beppu T, Shirabe K, Maehara Y, Baba H. Management of thrombocytopenia due to liver cirrhosis: A review. World J Gastroenterol 2014; 20(10): 2595-2605 [PMID: 24627595 DOI: 10.3748/wjg.v20.i10.2595] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 53] [Article Influence: 8.6] [Reference Citation Analysis]
8 Zubieta-Rodríguez R, Gómez-Correa J, Rodríguez-Amaya R, Ariza-Mejia KA, Toloza-Cuta NA. Hospital mortality in cirrhotic patients at a tertiary care center. Rev Gastroenterol Mex 2017;82:203-9. [PMID: 28433485 DOI: 10.1016/j.rgmx.2016.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Ho CK, Maselli JH, Terrault NA, Gonzales R. High Rate of Hospital Admissions Among Patients with Cirrhosis Seeking Care in US Emergency Departments. Dig Dis Sci 2015;60:2183-9. [PMID: 25724166 DOI: 10.1007/s10620-015-3594-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
10 Alomari M, Covut F, Al Momani L, Chadalavada P, Hitawala A, Young MF, Romero-Marrero C. Evaluation of the United Kingdom-primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population. JGH Open 2020;4:132-9. [PMID: 32280755 DOI: 10.1002/jgh3.12223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]